Tailored first-line biologic and targeted synthetic disease modifying anti-rheumatic drugs therapy in patients with rheumatoid arthritis: 2021 updated ITABIO statements
EXPERT OPINION ON DRUG SAFETY（2022）
Key words
Biologics,JAK-inhibitors,rheumatoid arthritis,extra-articular manifestations,tailored therapy,comorbidities
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined